Prevention and treatment of nosocomial sepsis in the NICU

Journal of Perinatology

Volumn 24, Issue 7, 2004, Pages 446-453

  Clark, Reese ^a,b   Powers, Richard ^c   White, Robert ^d   Bloom, Barry ^e   Sanchez, Pablo ^f   Benjamin Jr , Daniel K ^b  

^a Pediatrics Medical Group Inc   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Children's Mercy Hospital   (United States)

^d is an assistant professor of nursing at Bethel College   (United States)

^e WESLEY MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPHOTERICIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFAZOLIN; CEFOTAXIME; CEPHALOSPORIN; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; FLUCLOXACILLIN; FLUCYTOSINE; GLYCOPEPTIDE; IMMUNOGLOBULIN; IODINE; MINOCYCLINE; NAFCILLIN; OXACILLIN; PENICILLIN G; POVIDONE IODINE; RIFAMPICIN; SALICYLIC ACID; SILVER; SULFADIAZINE SILVER; TEICOPLANIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTISEPSIS; BLOOD CULTURE; BREAST MILK; CANDIDA; CATHETER INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEVICE REMOVAL; DISEASE SEVERITY; DISINFECTION; DRUG USE; ECHOCARDIOGRAPHY; ECHOGRAPHY; GRAM NEGATIVE BACTERIUM; HAND WASHING; HOSPITAL ADMISSION; HOSPITAL DESIGN; HOSPITAL INFECTION; HUMAN; INFANT FEEDING; LABORATORY TEST; LENGTH OF STAY; LUMBAR PUNCTURE; MEDICAL DECISION MAKING; MICROBIAL GROWTH; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN SEPSIS; OUTCOMES RESEARCH; PREDICTION; PROTECTIVE CLOTHING; PSEUDOMONAS; REVIEW; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; VASCULAR ACCESS;

ANTI-BACTERIAL AGENTS; BLOOD-BORNE PATHOGENS; CANDIDIASIS; CROSS INFECTION; HUMANS; HYGIENE; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; INFECTION CONTROL; INTENSIVE CARE UNITS, NEONATAL; PROCESS ASSESSMENT (HEALTH CARE); SEPSIS; VANCOMYCIN;

EID: 4043129057     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211125     Document Type: Review

References (139)

1. Adams-Chapman I, Stoll BJ. Prevention of nosocomial infections in the neonatal intensive care unit. Curr Opin Pediatr 2002;14(2):157-64.
2. Boyce JM, Rotter ML. Hospital hygiene procedures: areas of consensus and ongoing controversies. Proceeding of the 6th International BODE Hygiene Day 7-10 September 2000, Vienna, Austria. J Hosp Infect 2001;48(Suppl A): S1-92.
3. Boyce JM. Consequences of inaction: importance of infection control practices. Clin Infect Dis 2001;33(Suppl 3):S133-7.
4. Boyce JM. Antiseptic technology: access, affordability, and acceptance. Emerg Infect Dis 2001;7(2):231-3.
5. Boyce JM. Using alcohol for hand antisepsis: dispelling old myths. Infect Control Hosp Epidemiol 2000;21(7):438-41.
6. Boyce JM. It is time for action: improving hand hygiene in hospitals. Ann Intern Med 1999;130(2):153-5.
7. Ehrenkranz NJ, Sanders CC, Eckert-Schollenberger D. et al. Lack of evidence of efficacy of cohorting nursing personnel in a neonatal intensive care unit to prevent contact spread of bacteria: an experimental study. Pediatr Infect Dis J 1992;11(2):105-13.
8. Ehrenkranz NJ. Bland soap handwash or hand antisepis? The pressing need for clarity. Infect Control Hosp Epidemiol 1992;13(5):299-301.
9. Gould D. Infection control. Making sense of hand hygiene. Nurs Times 1994;90(30):63-4.
10. Perraud M, Amazian K, Girard R, Tissot GF. The use of hand hygiene products could reduce colonization on the hands. J Hosp Infect 2001;47(4):336-7.
11. Handwashing agents. Infect Control 1987;8(9):384-5.
12. Rahman M, Chattopadhyay B. Handwashing: unanswered questions and compliance. J Hosp Infect 2000;45(3):249-50.
13. CDC. Draft Guidline for Hand Hygiene in Healthcare Settings. CDC; 2002, Elsevier: England.
14. Dharan S, Mourouga P, Copin P, Bessmer G, Tschanz B, Pittet D. Routine disinfection of patients' environmental surfaces. Myth or reality? J Hosp Infect 1999;42(2):113-7.
15. Ayliffe GA, Babb JR, Davies JG, Lilly HA. Hand disinfection: a comparison of various agents in laboratory and ward studies. J Hosp Infect 1988;11(3):226-43.
16. Kjolen H, Andersen BM. Handwashing and disinfection of heavily contaminated hand - effective or ineffective? J Hosp Infect 1992;21(1):61-71.
17. Larson E, Silberger M, Jakob K, et al. Assessment of alternative hand hygiene regimens to improve skin health among neonatal intensive care unit nurses. Heart Lung 2000;29(2):136-42.
18. Pittet D. Compliance with hand disinfection and its impact on hospital-acquired infections. J Hosp Infect 2001;48(Suppl A):S40-6.
19. Pittet D. Improving adherance to hand hygiene practice: a multidisciplinary approach. Emerg Infect Dis 2001;7(2):234-40.
20. Pittet D. Promotion of hand hygiene: magic, hype, or scientific challenge? Infect Control Hosp Epidemiol 2002;23(3):118-9.
21. Boyce JM, Kelliher S, Vallande N. Skin irritation and dryness associated with two hand-hygiene regimens: soap-and-water hand washing versus hand antisepsis with an alcoholic hand gel. Infect Control Hosp Epidemiol 2000;21(7):442-8.
22. Doebbeling BN, Stanley GL, Sheetz CT et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992;327(2):88-93.
23. Larson EL, Laughon BE. Comparison of four antiseptic products containing chlorhexidine gluconate. Antimicrob Agents Chemother 1987;31(10): 1572-74.
24. Larson EL, Eke PI, Wilder MP, Laughon BE. Quantity of soap as a variable in handwashing. Infect Control 1987;8(9):371-5.
25. Hirschmann H, Fux L, Podusel J et al. The influence of hand hygiene prior to insertion of peripheral venous catheters on the frequency of complications. J Hosp Infect 2001;49(3):199-203.
26. Hugonnet S, Perneger TV, Pittet D. Alcohol-based handrub improves compliance with hand hygiene in intensive care units. Arch Intern Med 2002;162(9):1037-43.
27. Meengs MR, Giles BK, Chisholm CD, Cordell WH, Nelson DR. Hand washing frequency in an emergency department. Ann Emerg Med 1994;23(6); 1307-12.
28. Voss A, Widmer AF. No time for handwashing! Hand washing versus alcoholic rub: can we afford? 100% complaince? Infect Control Hosp Epidemiol 1997;18(3):205-8.
29. Muto CA, Sistrom MG, Farr BM. Hand hygiene rates unaffected by installation of dispensers of a rapidly acting hand antiseptic. Am J Infect Control 2000;28(3):273-6.
30. Sharek PJ, Benitz WE, Abel NJ, Freeburn MJ, Mayer ML, Bergman DA. Effect of an evidence-based hand washing policy on hand washing rates and false-positive coagulase negative staphylococcus blood and cerebrospinal fluid culture rates in a level III NICU. J Perinatol 2002;22(2):137-43.
31. Foca M, Jakob K, Whittier S et al. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Engl J Med 2000; 343(10):695-700.
32. Moolenaar RL, Crutcher JM, San Joaquin VH et al. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect Control Hosp Epidemiol 2000;21(2):80-5.
33. McNeil SA, Foster CL, Hedderwick SA, Kauffman CA. Effect of hand cleansing with antimicrobial soap or alcohol-based gel on microbial colonization of artificial fingernails worn by health care workers. Clin Infect Dis 2001;32(3):367-72.
34. Pottinger J, Burns S, Manske C. Bacterial carriage by artificial versus natural nails. Am J Infect Control 1989;17(6):340-4.
35. Narayanan I, Prakash K, Gujral VV. The value of human milk in the prevention of infection in the high-risk low-birth infant. J Pediatr 1981;99(3):496-8.
36. Hylander MA, Strobino DM, Dhanireddy R. Human milk feedings and infection among very low birth weight infants. Pediatrics 1998;102(3):E38.
37. Schanler RJ. The use of human milk for premature infants. Pediatr Clin North Am 2001;48(1):207-19.
38. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev 2001;(2):CD000361.
39. Jenson HB, Pollock BH. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis. Pediatrics 1997;99(2):E2.
40. Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev 2001;(2):CD001239.
41. American Institute of Architects. Guidelines for Design and Construction of Hospital and Health Care Facilities. Washington, DC: The American Institute of Architects; 2001.
42. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51(RR-10):1-29.
43. Garland JS, Henrickson K, Maki DG. The 2002 Hospital Infection Control Practices Advisory Committee Centers for Disease Control and Prevention guideline for prevention of intravascular device-related infection. Pediatrics 2002;110(5):1009-13.
44. Salzman MB, Isenberg HD, Shapiro JF, Lipsitz PJ, Rubin LG. A prospective study of the catheter hub as the portal of entry for micoorganisms causing catheter-related sepsis in neonates. J Infect Dis 1993;167(2):487-90.
45. Salzman MB, Rubin LG. Intravenous catheter-related infections. Adv Pediatr Infect Dis 1995;10:337-68.
46. Sitges-Serra A, Hernandez R, Maestro S, Pi-Suner T, Garces JM, Segura M. Prevention of catheter sepsis: the hub. Nutrition 1997;13(4 Suppl):30S-5S.
47. Sitges-Serra A, Girvent M, Catheter-related blodstream infections. World J Surg 1999;23(6):589-95.
48. Ng SP, Gomez JM, Lim SH, Ho NK. Reduction of nosocomial infection in a neonatal intensive care unit (NICU). Singapore Med J 1998;39(7):319-23.
49. Salzman MB, Isenberg HD, Rubin LG. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol 1993;31(3):475-9.
50. Segura M, Alia C, Oms L, Sancho JJ, Torres-Rodriguez JM, Sitges-Serra A. In vitro bacteriological study of a new hub model for intravascular catheters and infusion equipment. J Clin Microbiol 1989;27(12):2656-9.
51. Segura M, Alia C, Valverde J, Franch G, Torres Rodriguez JM, Sitges-Serra A. Assessment of a new hub design and the semiquantitative catheter culture method using an in vivo experimental model of catheter sepsis. J Clin Microbiol 1990;28(11):2551-4.
52. Segura M, Alvarez-Lerma F, Tellado JM et al. A clinical trial on the preventions of catheter-related sepsis using a new hub model. Ann Surg 1996;223(4):363-9.
53. Garland JS, Alex CP, Mueller CD et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001;107(6):1431-6.
54. Maki DG, Ringer M, Alvarado CJ. Propective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338(8763):339-43.
55. Raad II, Hohn DC, Gilbreath BJ et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15(4 Part 1):231-8.
56. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991;91(3B):197S-205S.
57. Lopez Sastre JB, Coto CD, Fernandez CB. "Neonatal sepsis of nosocomial origin: an epidemiology study from the "Group de Hospitales Castrillo". J Perinat Med 2002;30(2):149-57.
58. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 2002;109(1):34-9.
59. Nagata E, Brito AS, Matsuo T. Nosocomial infections in a neonatal intensive care unit: incidence and risk factors. Am J Infect Control 2002;30(1):26-31.
60. Chathas MK, Paton JB, Fisher DE. Percutaneous central venous catheterization. Three years' experience in a neonatal intensive care unit. Am J Dis Child 1990;144(11):1246-50.
61. Kennedy KA, Tyson JE, Chamnanvanikij S. Early versus delayed initiation of progressive enteral feedings for parenterally fed low birth weight or preterm infants. Cochrane Database Syst Rev 2000;(2):CD001970.
62. Kennedy KA, Tyson JE, Chamnanvanakij S. Rapid versus slow rate of advancement of feedings for promoting growth and preventing necrotizing enterocolitis in parenterally fed low-birth-weight infants. Cochrane Database Syst Rev 2000;(2):CD001241.
63. Craft AP, Finer NN, Barrington KJ. Vancomycin for prophylaxis against sepsis in preterm neonates. Cochrane Database Syst Rev 2000;(2):CD001971.
64. DeLisle S, Perl TM. Vancomycin-resistant enterococci: a road map on how to prevent the emergence and transmission of antimicrobial resistance. Chest 2003;123(5 Suppl):504S-18S.
65. Lai KK, Fontecchio SA, Kelly AL, Baker S, Melvin ZS. The changing epidemiology of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2003;24(4):264-8.
66. Pierce CM, Wade A, Mok Q. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med 2000;26(7):967-72.
67. Jansen B, Ruiten D, Pulverer G. In-vitro activity of a catheter loaded with silver and teicoplanin to prevent bacterial and fungal colonization. J Hosp Infect 1995;31(3):238-41.
68. McCarthy A, Rao JS, Byrne M, Breatnach F, O'Meara CA. Central venous catheter infections treated with teicoplanin. Eur J Haematol Suppl 1998;62:15-7.
69. Jansen B, Jansen S, Peters G, Pulverer G. In-vitro efficacy of a central venous catheter ('Hydrocath')loaded with teicoplanin to prevent bacterial colonization. J Hosp Infect 1992;22(2):93-107.
70. Kamal GD, Pfaller MA, Rempe LE, Jebson PJ. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 1991;265(18):2364-8.
71. Jansen B, Kristinsson KG, Jansen S, Peters G, Pulverer G. In-vitro efficacy of a central venous catheter complexed with iodine to prevent bacterial colonization. J Antimicrob Chemother 1992;30(2):135-9.
72. Kristinsson KG, Jansen B, Treitz U, Schumacher-Perdreau F, Peters G, Pulverer G. Antimicrobial activity of polymers coated with iodine-complexed polyvinylpyrrolidone. J Biomater Appl 1991;5(3):173-84.
73. Pai MP, Pendland SL, Danziger LH. Antimicrobial-coated/bonded and - impregnated intravascular catheters. Ann Pharmacother 2001;35(10):1255-63.
74. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999;281(3):261-7.
75. Elliott T. Intravascular catheter-related sepsis - novel methods of prevention. Intensive Care Med 2000;26(Suppl 1):S45-S50.
76. Hanley EM, Veeder A, Smith T, Drusano G, Currie E, Venezia RA. Evaluation of an antiseptic triple-lumen catheter in an intensive care unit. Crit Care Med 2000;28(2):366-70.
77. Darouiche RO, Raad II, Heard SO et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999;340(1):1-8.
78. Benjamin Jr. DK, Miller W, Garges H et al. Bacteremia, central catheters, and neonates: When to pull the line. Pediatrics 2001;107(6):1272-6.
79. Nazemi KJ, Buescher ES, Kelly Jr. RE, Karlowicz MG. Central venous catheter removal versus in situ treatment in neonates with enterobacteriaceae bacteremia. Pediatrics 2003;111(3):e269-74.
80. Karlowicz MG, Furigay PJ, Croitoru DP, Buescher ES. Central venous catheter removal versus in situ treatment in neonates with coagulase-negative staphylococcal bacteremia. Pediatr Infect Dis J 2002;21(1): 22-27.
81. Chapman RL, Faix RG. Persistent bacteremia and outcome in late onset infection among infants in a neonatal intensive care unit. Pediatr Infect Dis J 2003;22(1):17-21.
82. Bloom BT, Craddock A, Delmore PM et al. Reducing acquired infections in the NICU: observing and implementing meaningful differences in process between high and low acquired infection rate centers. J Perinatol 2003;23(6):489-92.
83. Long MN, Wickstrom G, Grimes A, Benton CF, Belcher B, Stamm AM. Prospective, randomized study of ventilator-associated pneumonia in patients with one versus three ventilator circuit changes per week. Infect Control Hosp Epidemiol 1996;17(1):14-9.
84. Cordero L, Sananes M, Ayers LW. Comparison of a closed (Trach Care MAC) with an open endotracheal suction system in small premature infants. J Perinatol 2000;20(3):151-6.
85. Deppe SA, Kelly JW, Thoi LL et al. Incidence of colonization, nosocomial pneumonia, and mortality in critically ill patients using a Trach Care closed-suction system versus an open-suction system: prospective, randomized study. Crit Care Med 1990;18(12):1389-93.
86. Tan SG, Lim SH, Malathi I. Does routine gowning reduce nosocomial infection and mortality rates in a neonatal nursery? A Singapore experience. Int J Nurs Pract 1995;1(1):52-8.
87. Donowitz LG. Failure of the overgown to prevent nosocomial infection in a pediatric intensive care unit. Pediatrics 1986;77(1):35-8.
88. Pelke S, Ching D, Easa D, Melish ME. Gowning does not affect colonization or infection rates in a neonatal intensive care unit. Arch Pediatr Adolesc Med 1994;148(10):1016-20.
89. Krediet TG, Beurskens FJ, van Dijk H, Gerards LJ, Fleer A. Antibody responses and opsonic activity in sera of preterm neonates with coagulase-negative staphylococcal septicemia and the effect of the administration of fresh frozen plasma. Pediatr Res 1998;43(5):645-51.
90. Burgner D. Fresh frozen plasma and neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 1994;71(3):F233.
91. Acunas BA, Peakman M, Liossis G et al. Effect of fresh frozen plasma and gammaglobulin on humoral immunity in neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 1994;70(3):F182-7.
92. Campbell JR, Zaccaria E, Baker CJ. Systemic candidiasis in extremely low birth weight infants receiving topical petrolatum ointment for skin care: a case-cotrol study. Pediatrcs 2000;105(5):1041-5.
93. Lund C, Kuller J, Lane A, Lott JW, Raines DA. Neonatal skin care: the scientific basis for practice. Neonatal Netw 1999;18(4):15-27.
94. Lund CH, Osborne JW, Kuller J, Lane AT, Lott JW, Raines DA. Neonatal skin care: clinical outcomes of the AWHONN/NANN evidence-based clinical practice guideline. Association of Women's Health, Obstetric and Neonatal Nurses and the National Association of Neonatal Nurses. J Obstet Gynecol Neonatal Nurs 2001;30(1):41-51.
95. Lund CH, Kuller J, Lane AT, Lott JW, Raines DA, Thomas KK. Neonatal skin care: evaluation of the AWHONN/NANN research-based practice project on knowledge and skin care practices. Association of Women's Health, Obstetric and Neonatal Nurses/National Association of Neonatal Nurses. J Obstet Gynecol Neonatal Nurs 2001;30(1):30-40.
96. Janota J, Stranak Z, Belohlavkova S. Interleukin-6, procalcitonin, C-reactive protein and the immature to total neutrophil ratio (I/T) in the diagnosis of early-onset sepsis in low birth weight neonates. Ceska Gynekol 2000;65(Suppl 1):29-33.
97. Magudumana MO, Ballot DE, Cooper PA et al. Serial interleukin 6 measurements in the early diagnosis of neonatal sepsis. J Trop Pediatr 2000;46(5):267-71.
98. Mehr S, Doyle L. Interleukin-6 concentrations in neonatal sepsis. Lancet 1999;353(9166):1798-9.
99. Yilmaz E, Gurgoze MK, Ilhan N, Dogan Y, Aydinoglu H. Interleukin-8 levels in children with bacterial, tubeculous and aseptic meningitis. Indian J Pediatr 2002;69(3):219-21.
100. Sikora JP, Chlebna-Sokol D, Krzyzanska-Oberbek A. Proinflammatory cytokines (IL-6, IL-8), cytokine inhibitors (IL-6sR, sTNFRII) and anti-inflammatory cytokinees (IL-10, IL-13) in the pathogenesis of sepsis in newborns and infants. Arch Immunol Ther Exp (Warsz) 2001;49(5): 399-404.
101. Schollin J. Interleukin-8 in neonatal sepsis. Acta Paediatr 2001;90(9): 961-2.
102. Mehr SS, Doyle LW, Rice GE, Vervaart P, Henschke P. Interleukin-6 and interleukin-8 in newborn bacterial infection. Am J Perinatol 2001;18(6):313-24.
103. Martin H, Olander B, Norman M. Reactive hyperemia and interleukin 6, interleukin 8, and tumor necrosis factor-alpha in the diagnosis of early-onset neonatal sepsis. Pediatrics 2001;108(4):E61.
104. Franz AR, Steinbach G, Kron M, Pohlandt F. Interleukin-8: a valuable tool to restrict antibiotic therapy in newborn infants. Acta Paediatr 2001;90(9):1025-32.
105. Franz AR, Steinbach G, Kron M, Pohlandt F. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics 1999;104(3 Part 1): 447-53.
106. Franz AR, Kron M, Pohlandt F, Steinbach G. Comparison of procalcitonin with interleukin 8, C-reactive protein and differential white blood cell count for the early diagnosis of bacterial infections in newborn infants. Pediatr Infect Dis J 1999;18(8):666-71.
107. Enguix A, Rey C, Concha A, Medina A, Coto D, Dieguez MA. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med 2001;27(1):211-5.
108. Ronnestad A, Abrahamsen TG, Gaustad P, Finne PH. C-reactive protein (CRP) response patterns in neonatal septicaemia. APMIS 1999;107(6): 593-600.
109. Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998;102(4):E41.
110. Pourcyrous M, Bada HS, Korones SB, Baselski V, Wong SP, Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 1993;92(3):431-5.
111. Ang AT, Ho NK, Chia SE. The usefulness of CPR and I/T ratio in early diagnosis of infections in Asian newborns. J Singapore Paediatr Soc 1990; 32(3-4):159-63.
112. Seibert K, Yu VY, Doery JC, Embury D. The value of C-reactive protein measurement in the diagnosis of neonatal infection. J Paediatr Child Health 1990;26(5):267-70.
113. de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000;355(9208):973-8.
114. Sinkowitz RL, Keyserling H, Walker TJ, Holland J, Jarvis WR. Epidemiology of vancomycin usage at a children's hospital, 1993 through 1995. Pediatr Infect Dis J 1997;16(5):485-9.
115. Stoll BJ, Hansen N, Fanaroff AA et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(2 Part 1):285-91.
116. Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a noenatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000;106(6):1387-90.
117. Benjamin Jr. DK, Ross K, McKinney Jr. RE, Benjamin DK, Auten R, Fisher RG. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 2000;106(4):712-8.
118. Garcia-Prats JA, Cooper TR, Schneider VF, Stager CE, Hansen TN. Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics 2000;105(3 Part 1):523-7.
119. Kumar Y, Qunibi M, Neal TJ, Yoxall CW. Time to positivity of neonatal blood cultures. Arch Dis Child Fetal Neonatal Ed 2001;85(3):F182-6.
120. Kaiser JR, Cassat JE, Lewno MJ. Should antibiotics be discontinued at 48 hours for negative late-onset sepsis evaluations in the neonatal intensive care unit? J Perinatol 2002;22(6):445-7.
121. Kurlat I, Stoll BJ, McGowan Jr. JE. Time to positivity for detection of bacteremia in neonates. J Clin Microbiol 1989;27(5):1068-71.
122. Pauli Jr. I, Shekhawat P, Kehl S, Sasidharan P. Early detection of bacteremia in the neonatal intensive care unit using the new BACTEC system. J Perinatol 1999;19(2):127-31.
123. Pichichero ME, Todd JK. Detection of neonatal bacteremia. J Pediatr 1979;94(6):958-60.
124. Hertz D, Fuller D, Davis T, Papeli L, Stevenson D, Lemons J. Comparison of DNA probe technology automated continuous-monitoring blood culture systems in the detection of neonatal bacteremia. J Perinatol 1999;19(4):290-3.
125. Rowley AH, Wald ER. Incubation period necessary to detect bacteremia in neonates. Pediatr Infect Dis 1986;5(5):590-1.
126. Kicklighter SD. Antifungal agents and fungal prophylaxis in the neonate. NeoReviews 2002;3(12):249e-255.
127. Hudome SM, Fisher MC. Nosocomial infections in the neonatal intensive care unit. Curr Opin Infect Dis 2001;14(3):303-7.
128. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001;345(23):1660-6.
129. Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB. Fluconazole for prohylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 2001;107(2):293-8.
130. Hurley R, Winner HI. Experimental moniliasis in the mouse. J Pathol Bacteriol 1963;86:75-81.
131. Hurley R. The pathogenicity of Candida stellatoidea. J Pathol Bacteriol 1965;90(1):351-4.
132. Beno DW, Mathews HL. Quantitative measurement of lymphocyte mediated growth inhibition of Candida albicans. J Immunol Methods 1993;164(2):155-64.
133. Rex JH, Walsh TJ, Anaissie EJ. Fungal infections in iatrogenically compromised hosts. Adv Intern Med 1998;43:321-71.
134. Hughes WT. Systemic candidiasis: a study of 109 fatal cases. Pediatr Infect Dis 1982;1(1):11-8.
135. Telenti A, Roberts GD. Fungal blood cultures. Eur J Clin Microbiol Infect Dis 1989;8(9):825-31.
136. Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis 1993;17(2):103-9.
137. Benjamin Jr. DK, Miller WC, Bayliff S, Martel L, Alexander KA, Martin PL. Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr Infect Dis J 2002;21(3):227-34.
138. Leibovitz E. Neonatal candidosis: clinical picture, management controversies and consensus, and new therapeutic options. J Antimicrob Chemoter 2002;49(Suppl 1):69-73.
139. Rex JH, Walsh TJ, Sobel JD et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000;30(4):662-78.